Improving Antibiotic Use in Urgent Care Facilities (SCORE_UC)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03932708|
Recruitment Status : Active, not recruiting
First Posted : May 1, 2019
Last Update Posted : February 10, 2021
|Condition or disease||Intervention/treatment||Phase|
|Antibiotic Side Effect Behavioral Changes||Behavioral: CDC Core Elements of Outpatient Stewardship||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||700000 participants|
|Intervention Model:||Single Group Assignment|
|Intervention Model Description:||This is a before/after study design. Its an implementation science project.|
|Masking:||None (Open Label)|
|Primary Purpose:||Health Services Research|
|Official Title:||Improving Antibiotic Use in Urgent Care Facilities Through Implementation and Evaluation of Core Elements of Outpatient Antibiotic Stewardship|
|Actual Study Start Date :||July 1, 2019|
|Estimated Primary Completion Date :||April 23, 2022|
|Estimated Study Completion Date :||April 23, 2022|
Experimental: Urgent Care Antibiotic Stewardship Intervention
All 38 urgent care clinics will implement CDC Core Elements of outpatient antibiotic stewardship as described above.
Behavioral: CDC Core Elements of Outpatient Stewardship
The intervention is described above and includes components of leadership, action of policy and practice, tracking and reporting, and education and expertise.
- Antibiotic prescribing for respiratory encounters measured at the encounter level [ Time Frame: Intervention period is one year ]Respiratory encounters are defined as an urgent care encounter for any ICD10 defined respiratory condition, excluding encounters with concomitant other infectious diseases codes.
- Antibiotic prescribing appropriateness in respiratory encounters [ Time Frame: Intervention period is one year ]The secondary outcome of antibiotic appropriateness will also be measured at the encounter level and will be estimated two ways: (i) in terms of rate of guideline-recommended antibiotics among selected respiratory diagnoses, and (ii) in terms of rate of antibiotic prescribing among respiratory diagnoses where no prescribing should occur (i.e., rate of "inappropriate" antibiotics).
- Diagnostic shifting [ Time Frame: Intervention period is one year ]The secondary outcome of diagnostic shifting will be measured at the provider level and characterize changes in the types of diagnoses used during respiratory encounters.
- Patient satisfaction [ Time Frame: Intervention period is one year ]As data availability allows, a secondary outcome of patient satisfaction will be measured at the patient encounter level in terms of a validated, patient satisfaction score. Patient satisfaction will be assessed using the "rate your provider" question. This question asks patients to rate their provider on a scale of 1 - 10 (1 being the worst, 10 being the best). Patient satisfaction scores will be explored in patients that receive antibiotics for tier 2 and 3 respiratory conditions and those that do not receive antibiotics for tier 2 and 3 respiratory conditions.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03932708
|United States, Utah|
|Intermountain Medical Center|
|Murray, Utah, United States, 84017|
|Principal Investigator:||Eddie Stenehjem, MD||Intermountain Health Care, Inc.|